Alembic Pharmaceuticals has received USFDA tentative approval for its generic Darolutamide tablets used in prostate cancer treatment. The approval applies to the 300 mg strength, positioning Alembic’s product as a generic equivalent to Nubeqa Tablets. With significant demand expected for this category, the company could gain momentum as it moves toward final commercialization.
Israeli Prime Minister Benjamin Netanyahu shared a video of himself working out at the gym days after information about his prostate cancer surgery and radiation treatment became public. The clip is widely viewed as a direct response to political rivals who have raised concerns about his age and health, as he tries to project strength and shut down the criticism.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Prime Minister Benjamin Netanyahu said he has successfully completed treatment for early-stage prostate cancer. The disclosure appeared in his official annual health report, delayed by two months amid the ongoing regional conflict involving Iran and its proxies. Netanyahu framed the update as a health matter already addressed, with the public notice arriving only after the report’s postponement.
A Lancet report warns prostate cancer incidence in India could double soon, making early detection a key defense against a looming health crisis. But the article argues that solving detection isn’t just about testing—it also requires unlearning assumptions tied to public awareness campaigns and how men respond to screening messaging.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
